trending Market Intelligence /marketintelligence/en/news-insights/trending/nX_24498_lIqHG7h7bqzuA2 content esgSubNav
In This List

Momenta Pharmaceuticals to raise up to $230M from common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Momenta Pharmaceuticals to raise up to $230M from common stock offering

Momenta Pharmaceuticals Inc. priced an underwritten public offering of its common stock to raise up to $230 million in gross proceeds.

The Cambridge, Mass.-based biotechnology company is offering $200 million worth of its shares. Underwriters will also receive an option to buy up to an additional $30 million of the company's common stock.

Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint lead book-running managers for the offering, while Stifel is acting as a book-running manager.